Thomas Cusack - Director at HERON THERAPEUTICS, INC. /DE/

Issuer-level insider activity

Role: Director
Issuer ticker: HRTX on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Thomas Cusack since 27 Oct 2025

Reported holdings for Thomas Cusack in HERON THERAPEUTICS, INC. /DE/

Form 4 holding Director

HERON THERAPEUTICS, INC. /DE/

Security class: Stock Option (Right to Buy)
Shares / value: 227,272
Estimated value: $249,999
Report date: 08 Nov 2025
Price: $1.10
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

HERON THERAPEUTICS, INC. /DE/

Security class: Common Stock
Shares / value: 53,960
Estimated value: $70,148
Report date: 30 Jan 2026
Price: $1.30
Ownership: Direct

Transaction history for Thomas Cusack in HERON THERAPEUTICS, INC. /DE/

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .